Brevan Howard Capital Management’s Agilon Health AGL Stock Holding History

Brevan Howard Capital Management’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$906K	Buy	+8,456	New	+$554K	0.01%	1118
2025 Q4	–	Sell	-2,714	Closed	-$69.9K	–	1731
2025 Q3	$69.9K	Sell	2,714 -10,301	-79%	-$389K	﹤0.01%	1886
2025 Q2	$748K	Buy	13,015 +3,496	+37%	+$280K	﹤0.01%	1200
2025 Q1	$1.03M	Buy	+9,519	New	+$828K	0.01%	488
2024 Q4	–	Sell	-1,098	Closed	-$108K	–	1010
2024 Q3	$108K	Buy	+1,098	New	+$142K	﹤0.01%	1068

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Brevan Howard Capital Management's AGL Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Agilon Health (AGL) in Q2 2026: 8,456 shares worth $906K. The stake represents 0.01% of the portfolio and ranks #1118 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in AGL as recently as Q3 2025.

Brevan Howard Capital Management first reported a position in AGL in Q3 2024 and has held it in 5 quarters since. The position peaked at $1.03M in Q1 2025. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

Brevan Howard Capital Management held 8,456 shares of Agilon Health worth $906K as of Q2 2026.
Agilon Health was a new Brevan Howard Capital Management position in Q2 2026.
Agilon Health made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1118 holding.
Brevan Howard Capital Management first reported a position in Agilon Health in Q3 2024 and has held it in 5 quarters since.
Brevan Howard Capital Management's Agilon Health position peaked at $1.03M in Q1 2025.
179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.